Journal of Rheumatic Diseases

Korean College of Rheumatology (대한류마티스학회)
권호 표지
DOI QR코드

DOI QR Code

The Prevalence and Features of Korean Gout Patients Using the National Health Insurance Corporation Database

국민건강보험공단 자료를 이용한 국내 거주 통풍 환자의 유병률과 특성에 관한 연구

  • Lee, Chan-Hee (Division of Rheumatology, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Sung, Na-Young (Institute of Health Insurance and Clinical Research, National Health Insurance Corporation Ilsan Hospital)
  • 이찬희 (국민건강보험공단 일산병원 류마티스내과) ;
  • 성나영 (국민건강보험공단 일산병원 연구소)
  • Published : 2011.06.30
⟨ Previous Next ⟩

Abstract

Objective. We wanted to evaluate the prevalence of gout and its features in Korean people using the National Health Insurance Corporation (NHIC) database. Methods. Using the NHIC database from 2001 to 2008, we selected the gout patients who were coded as having gout as a main diagnosis. From the total number of gout patients, we evaluated the prevalence of gout and its features. Results. The prevalence of gout prevalence was 0.171% in 2001 and 0.397% in 2008, and there was a 2.317 fold increased during over the 7 years. In 2008, the percentage of fifth and sixth decade patients was 48.5% and that of the male patients were 89.8% of the total gout patients. The increasing rate of the prevalence of gout during the same period was also higher in males (the male vs. female ratio was 5.3:1 in 2001 and 8.8:1 in 2008). The gout prevalence increased year by year to the eighth decade, and the peak prevalence age group was the ninth decade in 2001, the eighth decade in 2002-2005 and the seventh decade in 2006-2008. The prevalence ratio of 2008 to 2001 was higher for the males and the younger age group; that of third decade for males was 9.87, which was over the 10 times higher compared to that of the ninth decade (9.87 vs. 0.89, respectively). Conclusion. The prevalence of gout in 2008 using the NHIC database was 0.397%, so the prevalence of gout increased 2.317 fold over the 7 years, and nearly 90% of the gout patients were male. The increasing rate of gout prevalence was higher in the males and the younger age group.

Keywords

References

  1. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002;29:2403-6.
  2. Currie WJ. Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 1979;38:101-6. https://doi.org/10.1136/ard.38.2.101
  3. Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995; 48:1153-8. https://doi.org/10.1016/0895-4356(94)00244-K
  4. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72. https://doi.org/10.1136/ard.2004.024091
  5. Isomäki H, von Essen R, Ruutsalo HM. Gout, particularly diuretics-induced, is one the increase in Finland. Scand J Rheumatol 1977;6:213-6. https://doi.org/10.3109/03009747709095452
  6. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-6. https://doi.org/10.1136/ard.56.1.22
  7. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000;27:1045-50.
  8. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001; 28:1640-6.
  9. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8. https://doi.org/10.1001/archinte.165.7.742
  10. Yoo B. Serum uric acid levels in Korean adult population and their correlates. J Korean Rheum Assoc 1995;2:60-8.
  11. Kim EH, Jeon K, Park KW, Kim HJ, Ahn JK, Jeon CH, et al. The prevalence of gout among hyperuricemic population. J Korean Rheum Assoc 2004;11:7-13.
  12. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007;57:109-15. https://doi.org/10.1002/art.22466
  13. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35. https://doi.org/10.1002/art.23176
  14. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008;67:960-6.
  15. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11:229. https://doi.org/10.1186/ar2669
  16. Weaver AL. Epidemiology of gout. Cleve Clin J Med 2008;75 Suppl 5:S9-12.
  17. Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010;62: 1069-76. https://doi.org/10.1002/art.27338
  18. Korea National Statistical Office. Age-and-gender-specific population size 2005. p. 854, Daejeon, Korea National Statistical Office, 2006.
  19. Anagnostopoulos I, Zinzaras E, Alexiou I, Papathanasiou AA, Davas E, Koutroumpas A, et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 2010;11:98. https://doi.org/10.1186/1471-2474-11-98
  20. Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008;35: 1859-64.
  21. Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int 2009;29:481-90. https://doi.org/10.1007/s00296-008-0809-z
  22. Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005;17:341-5.
  23. Hak AE, Choi HK. Lifestyle and gout. Curr Opin Rheumatol 2008;20:179-86. https://doi.org/10.1097/BOR.0b013e3282f524a2
  24. Kim J. Using national health insurance data to vitalize the evidence-based health care: the current status and tasks. In: The Korean society for preventive medicine, The Korean society for preventive medicine winter symposium 2007. p. 1-28, Seoul, The Korean society for preventive medicine, 2007.
  25. Park BJ, Sung JH, Park KD, Seo SW, Kim SW. Report of the evaluation for validity of discharged diagnoses in Korean health insurance database. p. 223, Seoul, Seoul National University, 2003.
  26. Park IB, Kim DJ, Kim J, Kim H, Kim H, Min KW, et al. Current status of aspirin user in Korean diabetic patients using Korean health insurance database. J Korean Diabetes Assoc 2006;30:363-71. https://doi.org/10.4093/jkda.2006.30.5.363
  27. Kim J. Validity of health insurance data. In: Korean diabetes association-Health insurance review and assessment service; Task force team for basic statistical study of Korean diabetes mellitus, Diabetes in Korea 2007. p. 7-13, Seoul, Goldfishery, 2008.
  28. Park SK, Cheong HK, Ki M, Son YM, Kim H. Assessment of the availability of health insurance data for epidemiologic study of childhood aseptic meningitis. Korean J Prev Med 2003;36:349-58.
  29. Cheong HK, Park SK, Ki M, Lee K. Six year national trend of childhood aseptic meningitis incidence in Korea, 1996-2001. Korean J Epidemiol 2008;30:252-62. https://doi.org/10.4178/kje.2008.30.2.252
  30. Koh MJ, Han JT, Lee AK, Kim MK, Park SH. Construction of national health screening examinee cohort - Development of the validity test. p. 170, Seoul, National health insurance corporation, 2008.
  31. Park IS, Koh MJ, Kim HJ. Construction of national health screening examinee cohort - Validity test of National health insurance database (II). p. 112, Seoul, National health insurance corporation, 2009.
  32. Shin MH, Oh HK, Ahn YO. Ten year trend of cancer incidence in Seoul, Korea: 1993--2002. J Prev Med Public Health 2008;41:92-9. https://doi.org/10.3961/jpmph.2008.41.2.92

Cited by

  1. A tool for communication with decision-makers: limitations and utilization of studies on cost of illness vol.17, pp.4, 2011, https://doi.org/10.3350/kjhep.2011.17.4.258
  2. Survey of Current Trends for Diagnosis and Treatment in Korean Gout Patients vol.18, pp.3, 2011, https://doi.org/10.4078/jrd.2011.18.3.187
  3. Rising Gout, Life Threatening Public Enemy vol.18, pp.4, 2011, https://doi.org/10.4078/jrd.2011.18.4.234
  4. Chronic Tophaceous Gout of the Calf Mimicking Deep Venous Thrombosis vol.19, pp.3, 2012, https://doi.org/10.4078/jrd.2012.19.3.156
  5. 통풍 환자를 위한 웹기반 자가-관리 중재 프로그램이 통풍 관련 지식, 치료제 복용 순응도 및 자가-관리에 미치는 효과 vol.43, pp.4, 2011, https://doi.org/10.4040/jkan.2013.43.4.547
  6. The Efficacy and Safety of Febuxostat in Korean Patients with Gout vol.20, pp.5, 2011, https://doi.org/10.4078/jrd.2013.20.5.277
  7. The frequency of single nucleotide polymorphisms and their association with uric acid concentration based on data from genome-wide association studies in the Korean population vol.34, pp.6, 2011, https://doi.org/10.1007/s00296-013-2939-1
  8. Clinical factors and treatment outcomes associated with failure in the detection of urate crystal in patients with acute gouty arthritis vol.29, pp.3, 2011, https://doi.org/10.3904/kjim.2014.29.3.361
  9. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects vol.9, pp.None, 2015, https://doi.org/10.2147/dddt.s86884
  10. 통풍성 궤양의 수술적 절제 후 음압배액법을 통한 치료 vol.32, pp.1, 2011, https://doi.org/10.12701/yujm.2015.32.1.42
  11. The Prevalence of Gout and Its Risk Factors in Healthy Workers vol.28, pp.5, 2011, https://doi.org/10.18857/jkpt.2016.28.5.259
  12. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015 vol.37, pp.9, 2011, https://doi.org/10.1007/s00296-017-3768-4
  13. Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample vol.37, pp.9, 2018, https://doi.org/10.1007/s10067-018-4130-2
  14. Metabolic syndrome: prevalence and risk factors in Korean gout patients vol.33, pp.4, 2011, https://doi.org/10.3904/kjim.2016.062
  15. New Classification Criteria and Guideline for Management of Gout vol.93, pp.4, 2011, https://doi.org/10.3904/kjm.2018.93.4.344
  16. 건강한 성인 남성의 대사증후군 위험 예측인자로서 혈청 요산/크레아티닌 비율 vol.51, pp.1, 2011, https://doi.org/10.15324/kjcls.2019.51.1.42
  17. Women with Metabolic Syndrome and General Obesity Are at a Higher Risk for Significant Hyperuricemia Compared to Men vol.8, pp.6, 2019, https://doi.org/10.3390/jcm8060837
  18. Clinical features and risk factors for gout attacks during anti‐tuberculosis treatment: A case‐control study in South Korea vol.22, pp.10, 2011, https://doi.org/10.1111/1756-185x.13697
  19. Trends of Gout Prevalence in South Korea Based on Medical Utilization: A National Health Insurance Service Database (2002∼2015) vol.27, pp.3, 2011, https://doi.org/10.4078/jrd.2020.27.3.174
  20. Clinical Study Using Healthcare Claims Database vol.28, pp.3, 2011, https://doi.org/10.4078/jrd.2021.28.3.119